ClinicalTrials.gg
RecruitingNCT07656584DECAUpdated Jul 8, 2026

Implementation of Communication Disability Collection and Accommodations in Primary Care Settings

An interventional study of Implementation Support Package in Communication Disabilities, sponsored by NYU Langone Health. Recruiting at 5 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-08.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Sep 2025, registered Jun 2026).
  • Started Sep 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
126,870
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This multi-methods-multi-site study aims to adapt and evaluate the effects of an implementation support package of strategies to assist primary care clinics in documenting patients' communication disability (CD) and accommodation needs in the electronic health record (EHR) and providing communication accommodations through EHR data extraction, surveys, focus groups, interviews, and clinical practice observations.

02

Conditions studied

  • Communication Disabilities
03

In context

Communication Disorders

149 studies on the registry are indexed under Communication Disorders; 44 are open to participants now.

This study's planned enrollment of 126,870 is above the median of 40 across 124 interventional studies indexed under Communication Disorders.

Browse Communication Disorders studies →

Lead sponsor

NYU Langone Health is the lead sponsor of 1,430 studies on the registry; 258 are open to participants now.

Of its 235 completed or terminated interventional studies of FDA-regulated products, 197 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

EHR Data Extraction

  1. Adults 18+ years
  2. Patients who had at least one visit within the 21-month EHR data collection period at participating study clinics.

Clinic Leadership, Providers \& Clinic Staff

  1. Adults 18+ years
  2. Individuals of all genders and members of all racial and ethnic categories employed at participating study clinics will be eligible for inclusion. NYULH study personnel will enroll providers and staff referred for study inclusion from all participating study clinics; not just NYULH staff exclusively.

Patients

  1. Adults 18+ years
  2. Patients with communication disabilities seen at least once at participating study clinics during the 21-month study period.
  3. Patients who self-identify as proficient in English communication as defined by English being a preferred language, or self-reported ability to participate in an interview in English without the support of an interpreter.

Exclusion criteria

Exclusion Criteria:

EHR Data Extraction

  1. Patients whose records are unavailable due to technical issues.
  2. Patients who are not seen at least once at participating study clinics during the 21-month data collection period.
  3. Duplicate records (e.g., duplicative EHR records marked for deletion).
  4. Patients who have opted-out of research participation.

Clinic Leadership, Providers \& Clinic Staff Interviews and Focus Groups

  1. Being \<18 years old
  2. Not an employed member of a participating study clinic or potential end user of the study implementation strategy.

Patient Interviews

  1. Being \<18 years old
  2. Patients without communication disabilities.
  3. Patients with communication disabilities seen outside of participating study clinics.
  4. Patients who are unable to provide consent for themselves.
  5. Patients who report not being proficient in English communication or self-reported inability to participate in an interview in English without the support of an interpreter.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
126,870 participants (estimated)

Study arms

  • Experimental
    Implementation Support Package Clinics

    Clinics will receive an implementation support package, designed to integrate patients' disability status into the EHR and provide accommodations for patients with CD

    Behavioral: Implementation Support Package

  • No intervention
    Control Clinics

    Clinics will not receive the implementation support package for patients with CD.

Interventions

  • BehavioralImplementation Support Package

    The implementation support package includes materials, activities, and procedures ready for use in diverse primary care practices and will facilitate each clinic's determination of how they will implement collection of disability status and provision of accommodations.

06

What researchers measure

Primary outcomes

  1. (Aim 2) Patient Reach

    Percent of patients who have a visit during the time of data collection and have the communication disability field completed in the EHR. A positive outcome for having the communication disability field completed in the EHR will be "no disability" "speech/language disability", "hearing disability", "decline", or "other" documented in the EHR, while a negative outcome will be the CD fields being left blank. All adult patients who are seen in each clinic are eligible to have their disability status documented, regardless of the type of visit.

    Time frame: Baseline, Implementation Follow Up (Approximately Month 9), Maintenance Follow Up (Approximately Month 21)

  2. (Aim 3) Adoption

    Adoption assessed for all the patients with a recorded accommodation need; measured as the percentage of clinical encounters in which the accommodation was provided and used, as ascertained through the EHR.

    Time frame: Implementation Follow Up (Approximately Month 9), Maintenance Follow Up (Approximately Month 21)

07

Study locations

5 of 5 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The de-identified participant data from the final research dataset will be deposited to the digital repository of the Inter-university Consortium for Political and Social Research (ICPSR) to ensure that the research community has long-term access to the data. These files may be accessed directly through the ICPSR website. After agreeing to Terms of Use, users with an ICPSR My Data account and an authorized IP address from a member institution may download the data, and non-members may purchase the files. The research data from this project will be supplied to ICPSR for permanent storage at the end of the project and incrementally; all data not otherwise published by the end of the grant period will be embargoed for one year to allow finalizations of manuscripts and data preparation for sharing. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.

Supporting information: Study protocol, Statistical analysis plan

Time frame: The research data from this project will be supplied to ICPSR for permanent storage at the end of the project and incrementally; all data not otherwise published by the end of the grant period will be embargoed for one year to allow finalizations of manuscripts and data preparation for sharing.

Access criteria: Users with an ICPSR My Data account and an authorized IP address from a member institution may download the data, and non-members may purchase the files.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07656584
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
Jun 18, 2026
Start date
Sep 1, 2025
Primary completion
Mar 30, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Jul 8, 2026

Study contacts

Megan Morris, PhD
Contact
megan.morris@nyulangone.org
646-501-0027
Sankeerth Jinna
Contact
sankeerth.jinna@nyulangone.org
2122630844
Megan Morris, PhD
principal investigator · megan.morris@nyulangone.org

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion